MWA
IDXX icon

Motive Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Motive Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,024
Closed -$359K – 67
2022
Q2 		$359K Buy
+1,024
New +$418K 0.28% 53

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Motive Wealth Advisors's IDXX Position: Q3 2022 in Review

Motive Wealth Advisors sold out of Idexx Laboratories (IDXX) in Q3 2022, closing a stake of 1,024 shares — an estimated $359K sold.

Motive Wealth Advisors first reported a position in IDXX in Q2 2022 and held it in 1 quarter. The position peaked at $359K in Q2 2022. 924 funds tracked by Wall St. Rank hold IDXX as of Q3 2022.

  • Motive Wealth Advisors reported no remaining Idexx Laboratories position as of Q3 2022 after selling out during the quarter.
  • Motive Wealth Advisors sold 1,024 Idexx Laboratories shares in Q3 2022, an estimated $359K.
  • Motive Wealth Advisors first reported a position in Idexx Laboratories in Q2 2022 and held it in 1 quarter.
  • Motive Wealth Advisors's Idexx Laboratories position peaked at $359K in Q2 2022.
  • 924 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2022.

Based on Motive Wealth Advisors's 13F filing for Q3 2022, filed 21 Oct 2022.